M. van Heek
CNS/CV Pharmacology
Schering-Plough Research Institute
Kenilworth
New Jersey 07033
USA
Name/email consistency: high
- The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys. van Heek, M., Compton, D.S., Davis, H.R. Eur. J. Pharmacol. (2001)
- Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters. van Heek, M., Austin, T.M., Farley, C., Cook, J.A., Tetzloff, G.G., Davis, H.R. Diabetes (2001)
- Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. van Heek, M., Farley, C., Compton, D.S., Hoos, L., Davis, H.R. Br. J. Pharmacol. (2001)
- Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. van Heek, M., Farley, C., Compton, D.S., Hoos, L., Alton, K.B., Sybertz, E.J., Davis, H.R. Br. J. Pharmacol. (2000)